Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 361

1.

Correction: SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience.

Mangia A, Piazzolla V, Giannelli A, Visaggi E, Minerva N, Palmieri V, Carraturo I, Potenza D, Napoli N, Lauletta G, Tagarielli V, Santoro R, Piccigallo E, De Gioia S, Chimenti A, Cuccorese G, Metrangolo A, Mazzola M, Agostinacchio E, Mennea G, Sabbà C, Cela M, Copetti M, Losappio R.

PLoS One. 2019 Sep 25;14(9):e0223287. doi: 10.1371/journal.pone.0223287. eCollection 2019.

2.

Should Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients?

Mangia A, Saponaro C, Vagheggini A, Opinto G, Centonze M, Vicenti C, Popescu O, Pastena M, Giotta F, Silvestris N.

Cancers (Basel). 2019 Sep 18;11(9). pii: E1393. doi: 10.3390/cancers11091393.

3.

Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue.

Ciavarella S, Vegliante MC, Fabbri M, De Summa S, Melle F, Motta G, De Iuliis V, Opinto G, Enjuanes A, Rega S, Gulino A, Agostinelli C, Scattone A, Tommasi S, Mangia A, Mele F, Simone G, Zito AF, Ingravallo G, Vitolo U, Chiappella A, Tarella C, Gianni AM, Rambaldi A, Zinzani PL, Casadei B, Derenzini E, Loseto G, Pileri A, Tabanelli V, Fiori S, Rivas-Delgado A, López-Guillermo A, Venesio T, Sapino A, Campo E, Tripodo C, Guarini A, Pileri SA.

Ann Oncol. 2019 Sep 20. pii: mdz386. doi: 10.1093/annonc/mdz386. [Epub ahead of print] No abstract available.

PMID:
31539020
4.

Patients With Nonalcoholic Steatohepatitis Experience Severe Impairment of Health-Related Quality of Life.

Younossi ZM, Stepanova M, Lawitz EJ, Reddy KR, Wai-Sun Wong V, Mangia A, Muir AJ, Jacobson I, Djedjos CS, Gaggar A, Myers RP, Younossi I, Nader F, Racila A.

Am J Gastroenterol. 2019 Oct;114(10):1636-1641. doi: 10.14309/ajg.0000000000000375.

PMID:
31464743
5.

Inertial Sensors in Swimming: Detection of Stroke Phases through 3D Wrist Trajectory.

Cortesi M, Giovanardi A, Gatta G, Mangia AL, Bartolomei S, Fantozzi S.

J Sports Sci Med. 2019 Aug 1;18(3):438-447. eCollection 2019 Sep.

6.

Independent Negative Prognostic Role of TCF1 Expression within the Wnt/β-Catenin Signaling Pathway in Primary Breast Cancer Patients.

Saponaro C, Scarpi E, Zito FA, Giotta F, Silvestris N, Mangia A.

Cancers (Basel). 2019 Jul 22;11(7). pii: E1035. doi: 10.3390/cancers11071035.

7.

SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience.

Mangia A, Piazzolla V, Giannelli A, Visaggi E, Minerva N, Palmieri V, Carraturo I, Potenza D, Napoli N, Lauletta G, Tagarielli V, Santoro R, Piccigallo E, De Gioia S, Chimenti A, Cuccorese G, Metrangolo A, Mazzola M, Agostinacchio E, Mennea G, Sabbà C, Cela M, Copetti M, Losappio R.

PLoS One. 2019 May 15;14(5):e0215783. doi: 10.1371/journal.pone.0215783. eCollection 2019. Erratum in: PLoS One. 2019 Sep 25;14(9):e0223287.

8.

Performance of Three Common Hepatitis C Virus (HCV) Genotyping Assays for Identification of HCV Genotype 2/1 Chimeras.

Peiffer KH, Kuhnhenn L, Stelzl E, Dietz J, Susser S, Tal AO, Finkelmeier F, Zuckerman E, Cornberg M, Barak M, Piazzolla V, Mangia A, Zeuzem S, Kessler HH, Vermehren J, Sarrazin C.

J Clin Microbiol. 2019 Jun 25;57(7). pii: e00060-19. doi: 10.1128/JCM.00060-19. Print 2019 Jul.

PMID:
31043467
9.

SVR12 Higher than 97% in GT3 Cirrhotic Patients with Evidence of Portal Hypertension Treated with SOF/VEL without Ribavirin: A Nation-Wide Cohort Study.

Mangia A, Cenderello G, Copetti M, Verucchi G, Piazzolla V, Lorusso C, Santoro R, Squillante MM, Orlandini A, Minisini R, Ciancio A.

Cells. 2019 Apr 4;8(4). pii: E313. doi: 10.3390/cells8040313.

10.

The Italian Rare Pancreatic Exocrine Cancer Initiative.

Brunetti O, Luchini C, Argentiero A, Tommasi S, Mangia A, Aprile G, Marchetti P, Vasile E, Casadei Gardini A, Scartozzi M, Barni S, Delfanti S, De Vita F, Di Costanzo F, Milella M, Cella CA, Berardi R, Cataldo I, Santini D, Doglioni C, Maiello E, Lawlor RT, Mazzaferro V, Lonardi S, Giuliante F, Brandi G, Scarpa A, Cascinu S, Silvestris N.

Tumori. 2019 Aug;105(4):353-358. doi: 10.1177/0300891619839461. Epub 2019 Apr 9.

PMID:
30967031
11.

Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.

Boni C, Janssen HLA, Rossi M, Yoon SK, Vecchi A, Barili V, Yoshida EM, Trinh H, Rodell TC, Laccabue D, Alfieri A, Brillo F, Fisicaro P, Acerbi G, Pedrazzi G, Andreone P, Cursaro C, Margotti M, Santoro R, Piazzolla V, Brunetto MR, Coco B, Cavallone D, Zhao Y, Joshi A, Woo J, Lau AH, Gaggar A, Subramanian GM, Massetto B, Fung S, Ahn SH, Ma X, Mangia A, Ferrari C.

Gastroenterology. 2019 Jul;157(1):227-241.e7. doi: 10.1053/j.gastro.2019.03.044. Epub 2019 Mar 28.

PMID:
30930022
12.

A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms.

Sharkawy RE, Bayoumi A, Metwally M, Mangia A, Berg T, Romero-Gomez M, Abate ML, Irving WL, Sheridan D, Dore GJ, Spengler U, Lampertico P, Bugianesi E, Weltman M, Mollison L, Cheng W, Riordan S, Santoro R, Gallego-Durán R, Fischer J, Nattermann J, D'Ambrosio R, McLeod D, Powell E, Latchoumanin O, Thabet K, Najim MAM, Douglas MW, Liddle C, Qiao L, George J, Eslam M; International Liver Disease Genetics Consortium (ILDGC).

Sci Rep. 2019 Feb 5;9(1):1439. doi: 10.1038/s41598-018-35736-2.

13.

Genome Wide Association Study Identifies Genetic Variants Associated With Early And Sustained Response To (Peg)Interferon In Chronic Hepatitis B Patients: The GIANT-B Study.

Brouwer WP, Chan HL, Lampertico P, Hou J, Tangkijvanich P, Reesink HW, Zhang W, Mangia A, Tanwandee T, Montalto G, Simon K, Ormeci N, Chen L, Tabak F, Gunsar F, Flisiak R, Ferenci P, Akdogan M, Akyuz F, Hirankarn N, Jansen L, Wong Wai-Sun V, Soffredini R, Liang X, Chen S, Groothuismink ZM, Santoro R, Jaroszewicz J, Ozaras R, Kozbial K, Brahmania M, Xie Q, Chotiyaputta W, Xun Q, Pazgan-Simon M, Oztas E, Verhey E, Montanari NR, Sun J, Hansen BE, Boonstra A, Janssen H; GIANT-B Global Consortium.

Clin Infect Dis. 2019 Feb 2. doi: 10.1093/cid/ciz084. [Epub ahead of print]

PMID:
30715261
14.

Intratumoral, rather than stromal, CD8+ T cells could be a potential negative prognostic marker in invasive breast cancer patients.

Catacchio I, Silvestris N, Scarpi E, Schirosi L, Scattone A, Mangia A.

Transl Oncol. 2019 Mar;12(3):585-595. doi: 10.1016/j.tranon.2018.12.005. Epub 2019 Jan 22.

15.

Magnetometer Calibration and Field Mapping through Thin Plate Splines.

Muraccini M, Mangia AL, Lannocca M, Cappello A.

Sensors (Basel). 2019 Jan 11;19(2). pii: E280. doi: 10.3390/s19020280.

16.

Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus.

Vergara C, Thio CL, Johnson E, Kral AH, O'Brien TR, Goedert JJ, Mangia A, Piazzolla V, Mehta SH, Kirk GD, Kim AY, Lauer GM, Chung RT, Cox AL, Peters MG, Khakoo SI, Alric L, Cramp ME, Donfield SM, Edlin BR, Busch MP, Alexander G, Rosen HR, Murphy EL, Latanich R, Wojcik GL, Taub MA, Valencia A, Thomas DL, Duggal P.

Gastroenterology. 2019 Apr;156(5):1496-1507.e7. doi: 10.1053/j.gastro.2018.12.014. Epub 2018 Dec 26.

PMID:
30593799
17.

Discordance between FISH, IHC, and NGS Analysis of ALK Status in Advanced Non-Small Cell Lung Cancer (NSCLC): a Brief Report of 7 Cases.

Scattone A, Catino A, Schirosi L, Caldarola L, Tommasi S, Lacalamita R, Montagna ES, Galetta D, Serio G, Zito FA, Mangia A.

Transl Oncol. 2019 Feb;12(2):389-395. doi: 10.1016/j.tranon.2018.11.006. Epub 2018 Dec 4.

18.

Optimising management of patients with hepatitis C virus in the age of direct-acting antivirals: results of a Delphi consensus.

Di Marco V, Alberti A, Angarano G, Colombo M, Di Perri G, Gaeta GB, Ippolito G, Mangia A, Pasqualetti P, Craxì A.

Eur Rev Med Pharmacol Sci. 2018 Oct;22(20):7024-7033. doi: 10.26355/eurrev_201810_16174.

19.

Optimizing patient referral and center capacity in the management of chronic hepatitis C: Lessons from the Italian experience.

Alberti A, Angarano G, Colombo M, Craxì A, Di Marco V, Di Perri G, Gaeta GB, Ippolito G, Mangia A, Pasqualetti P.

Clin Res Hepatol Gastroenterol. 2019 Apr;43(2):190-200. doi: 10.1016/j.clinre.2018.09.007. Epub 2018 Oct 28.

20.

Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue.

Ciavarella S, Vegliante MC, Fabbri M, De Summa S, Melle F, Motta G, De Iuliis V, Opinto G, Enjuanes A, Rega S, Gulino A, Agostinelli C, Scattone A, Tommasi S, Mangia A, Mele F, Simone G, Zito AF, Ingravallo G, Vitolo U, Chiappella A, Tarella C, Gianni AM, Rambaldi A, Zinzani PL, Casadei B, Derenzini E, Loseto G, Pileri A, Tabanelli V, Fiori S, Rivas-Delgado A, López-Guillermo A, Venesio T, Sapino A, Campo E, Tripodo C, Guarini A, Pileri SA.

Ann Oncol. 2018 Dec 1;29(12):2363-2370. doi: 10.1093/annonc/mdy450.

21.

A Gradient-Based Approach for Breast DCE-MRI Analysis.

Losurdo L, Basile TMA, Fanizzi A, Bellotti R, Bottigli U, Carbonara R, Dentamaro R, Diacono D, Didonna V, Lombardi A, Giotta F, Guaragnella C, Mangia A, Massafra R, Tamborra P, Tangaro S, La Forgia D.

Biomed Res Int. 2018 May 16;2018:9032408. doi: 10.1155/2018/9032408. eCollection 2018.

22.

Real life rates of sustained virological response (SVR) and predictors of relapse following DAA treatment in genotype 3 (GT3) patients with advanced fibrosis/cirrhosis.

Mangia A, Losappio R, Cenderello G, Potenza D, Mazzola M, De Stefano G, Terreni N, Copetti M, Minerva N, Piazzola V, Bacca D, Palmieri V, Sogari F, Santoro R.

PLoS One. 2018 Jul 31;13(7):e0200568. doi: 10.1371/journal.pone.0200568. eCollection 2018.

23.

Heart rate recovery is associated with ventilatory constraints and excess ventilation during exercise in patients with chronic obstructive pulmonary disease.

Crisafulli E, Vigna M, Ielpo A, Tzani P, Mangia A, Teopompi E, Aiello M, Alfieri V, Bertorelli G, Palange P, Chetta A.

Eur J Prev Cardiol. 2018 Oct;25(15):1667-1674. doi: 10.1177/2047487318789756. Epub 2018 Jul 23.

PMID:
30033754
24.

A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B.

El Sharkawy R, Thabet K, Lampertico P, Petta S, Mangia A, Berg T, Metwally M, Bayoumi A, Boonstra A, Brouwer WP, Smedile A, Abate ML, Loglio A, Douglas MW, Khan A, Santoro R, Fischer J, Leeming DJ, Liddle C, George J, Eslam M.

Aliment Pharmacol Ther. 2018 Sep;48(5):564-573. doi: 10.1111/apt.14866. Epub 2018 Jul 2.

PMID:
29963713
25.

Bcl6/p53 expression, macrophages/mast cells infiltration and microvascular density in invasive breast carcinoma.

Tamma R, Ruggieri S, Annese T, Simone G, Mangia A, Rega S, Zito FA, Nico B, Ribatti D.

Oncotarget. 2018 Apr 27;9(32):22727-22740. doi: 10.18632/oncotarget.25220. eCollection 2018 Apr 27.

26.

Sinc-Windowing and Multiple Correlation Coefficients Improve SSVEP Recognition Based on Canonical Correlation Analysis.

Mondini V, Mangia AL, Talevi L, Cappello A.

Comput Intell Neurosci. 2018 Apr 12;2018:4278782. doi: 10.1155/2018/4278782. eCollection 2018.

27.

Immune Prophets of Lung Cancer: The Prognostic and Predictive Landscape of Cellular and Molecular Immune Markers.

Catacchio I, Scattone A, Silvestris N, Mangia A.

Transl Oncol. 2018 Jun;11(3):825-835. doi: 10.1016/j.tranon.2018.04.006. Epub 2018 May 3. Review.

28.

NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma.

Saponaro C, Vagheggini A, Scarpi E, Centonze M, Catacchio I, Popescu O, Pastena MI, Giotta F, Silvestris N, Mangia A.

J Exp Clin Cancer Res. 2018 May 2;37(1):96. doi: 10.1186/s13046-018-0766-7.

29.

Effect of hepatitis B virus on steatosis in hepatitis C virus co-infected subjects: A multi-centre study and systematic review.

Goossens N, de Vito C, Mangia A, Clément S, Cenderello G, Barrera F, D'Ambrosio R, Coppola N, Zampino R, Stanzione M, Adinolfi LE, Wedemeyer H, Semmo N, Müllhaupt B, Semela D, Malinverni R, Moradpour D, Heim M, Trincucci G, Rubbia-Brandt L, Negro F; BOSTIC Study Group.

J Viral Hepat. 2018 Aug;25(8):920-929. doi: 10.1111/jvh.12891. Epub 2018 Apr 17. Review.

PMID:
29532619
31.

NHERF1 Between Promises and Hopes: Overview on Cancer and Prospective Openings.

Centonze M, Saponaro C, Mangia A.

Transl Oncol. 2018 Apr;11(2):374-390. doi: 10.1016/j.tranon.2018.01.006. Epub 2018 Feb 20. Review.

32.

What clinical, functional, and psychological factors before treatment are predictors of poor quality of life in cancer patients at the end of chemotherapy?

Mangia AS, Coqueiro NLO, Azevedo FC, Araujo HTDS, Amorim EO, Alves CNR, Camargo C, Fonseca AJD.

Rev Assoc Med Bras (1992). 2017 Nov;63(11):978-987. doi: 10.1590/1806-9282.63.11.978.

33.

Frizzled-10 and cancer progression: Is it a new prognostic marker?

Scavo MP, Fucci L, Caldarola L, Mangia A, Azzariti A, Simone G, Gasparini G, Krol S.

Oncotarget. 2017 Dec 12;9(1):824-830. doi: 10.18632/oncotarget.23159. eCollection 2018 Jan 2.

34.

TLR7 Agonist Increases Responses of Hepatitis B Virus-Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues.

Boni C, Vecchi A, Rossi M, Laccabue D, Giuberti T, Alfieri A, Lampertico P, Grossi G, Facchetti F, Brunetto MR, Coco B, Cavallone D, Mangia A, Santoro R, Piazzolla V, Lau A, Gaggar A, Subramanian GM, Ferrari C.

Gastroenterology. 2018 May;154(6):1764-1777.e7. doi: 10.1053/j.gastro.2018.01.030. Epub 2018 Jan 31.

PMID:
29378197
35.

Fine-mapping of genetic loci driving spontaneous clearance of hepatitis C virus infection.

Huang H, Duggal P, Thio CL, Latanich R, Goedert JJ, Mangia A, Cox AL, Kirk GD, Mehta S, Aneja J, Alric L, Donfield SM, Cramp ME, Khakoo SI, Tobler LH, Busch M, Alexander GJ, Rosen HR, Edlin BR, Segal FP, Lauer GM, Thomas DL, Daly MJ, Chung RT, Kim AY.

Sci Rep. 2017 Nov 20;7(1):15843. doi: 10.1038/s41598-017-16011-2.

36.

Hierarchical clustering analysis identifies metastatic colorectal cancers patients with more aggressive phenotype.

Opinto G, Silvestris N, Centonze M, Graziano G, Pinto R, Fucci L, Simone G, Mangia A.

Oncotarget. 2017 Sep 23;8(50):87782-87794. doi: 10.18632/oncotarget.21213. eCollection 2017 Oct 20.

37.

Intrapatient viral diversity and treatment outcome in patients with genotype 3a hepatitis C virus infection on sofosbuvir-containing regimens.

Bhardwaj N, Ragonnet-Cronin M, Murrell B, Chodavarapu K, Martin R, Chang S, Miller MD, Feld JJ, Sulkowski M, Mangia A, Wertheim JO, Osinusi A, McNally J, Brainard D, Mo H, Svarovskaia ES.

J Viral Hepat. 2018 Apr;25(4):344-353. doi: 10.1111/jvh.12825. Epub 2017 Dec 28.

PMID:
29112331
38.

NHERF1 together with PARP1 and BRCA1 expression as a new potential biomarker to stratify breast cancer patients.

Mangia A, Scarpi E, Partipilo G, Schirosi L, Opinto G, Giotta F, Simone G.

Oncotarget. 2017 Jul 22;8(39):65730-65742. doi: 10.18632/oncotarget.19444. eCollection 2017 Sep 12.

39.

TLL1 rs17047200 Increases the Risk of Fibrosis Progression in Caucasian Patients With Chronic Hepatitis C.

John M, Metwally M, Mangia A, Romero-Gomez M, Berg T, Sheridan D, George J, Eslam M.

Gastroenterology. 2017 Nov;153(5):1448-1449. doi: 10.1053/j.gastro.2017.04.056. Epub 2017 Oct 6. No abstract available.

PMID:
28993163
40.

Next generation beta adrenoreceptor agonists for the treatment of asthma.

Crisafulli E, Frizzelli A, Fantin A, Manco A, Mangia A, Pisi G, Fainardi V, Alfieri V, Aiello M, Bertorelli G, Chetta A.

Expert Opin Pharmacother. 2017 Oct;18(14):1499-1505. doi: 10.1080/14656566.2017.1378348. Epub 2017 Sep 14. Review.

PMID:
28891349
41.

Grape seed extracts modify the outcome of oxaliplatin in colon cancer cells by interfering with cellular mechanisms of drug cytotoxicity.

Porcelli L, Iacobazzi RM, Quatrale AE, Bergamini C, Denora N, Crupi P, Antonacci D, Mangia A, Simone G, Silvestris N, Azzariti A.

Oncotarget. 2017 Feb 7;8(31):50845-50863. doi: 10.18632/oncotarget.15139. eCollection 2017 Aug 1.

42.

Editorial: good news to patients with thalassaemia-HCV clearance made easy with direct acting antivirals. Authors' reply.

Mangia A, Piazzolla V, Santoro R.

Aliment Pharmacol Ther. 2017 Sep;46(6):629-630. doi: 10.1111/apt.14251. No abstract available.

43.

Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosis.

Asselah T, Bourgeois S, Pianko S, Zeuzem S, Sulkowski M, Foster GR, Han L, McNally J, Osinusi A, Brainard DM, Subramanian GM, Gane EJ, Feld JJ, Mangia A.

Liver Int. 2018 Mar;38(3):443-450. doi: 10.1111/liv.13534. Epub 2017 Oct 22.

PMID:
28756625
44.

Transcallosal Inhibition during Motor Imagery: Analysis of a Neural Mass Model.

Mangia AL, Ursino M, Lannocca M, Cappello A.

Front Comput Neurosci. 2017 Jun 30;11:57. doi: 10.3389/fncom.2017.00057. eCollection 2017.

45.

VEGF and TWIST1 in a 16-biomarker immunoprofile useful for prognosis of breast cancer patients.

Schirosi L, De Summa S, Tommasi S, Paradiso A, Gasparini G, Popescu O, Simone G, Mangia A.

Int J Cancer. 2017 Nov 1;141(9):1901-1911. doi: 10.1002/ijc.30868. Epub 2017 Jul 20.

46.

Randomised clinical trial: sofosbuvir and ledipasvir in patients with transfusion-dependent thalassaemia and HCV genotype 1 or 4 infection.

Mangia A, Sarli R, Gamberini R, Piga A, Cenderello G, Piazzolla V, Santoro R, Caruso V, Quarta A, Ganga R, Copetti M, Forni G.

Aliment Pharmacol Ther. 2017 Aug;46(4):424-431. doi: 10.1111/apt.14197. Epub 2017 Jun 29.

47.

Long-term persistence of HCV NS5A resistance-associated substitutions after treatment with the HCV NS5A inhibitor, ledipasvir, without sofosbuvir.

Wyles D, Mangia A, Cheng W, Shafran S, Schwabe C, Ouyang W, Hedskog C, McNally J, Brainard DM, Doehle BP, Svarovskaia E, Miller MD, Mo H, Dvory-Sobol H.

Antivir Ther. 2018;23(3):229-238. doi: 10.3851/IMP3181.

PMID:
28650844
48.

Origin, prevalence and response to therapy of hepatitis C virus genotype 2k/1b chimeras.

Susser S, Dietz J, Schlevogt B, Zuckerman E, Barak M, Piazzolla V, Howe A, Hinrichsen H, Passmann S, Daniel R, Cornberg M, Mangia A, Zeuzem S, Sarrazin C.

J Hepatol. 2017 Oct;67(4):680-686. doi: 10.1016/j.jhep.2017.05.027. Epub 2017 Jun 13.

PMID:
28619439
49.

Efficacy and safety profile of boceprevir- or telaprevir-based triple therapy or dual peginterferon alfa-2a or alfa-2b plus ribavirin therapy in chronic hepatitis C: the real-world PegBase observational study.

Mangia A, Foster GR, Berg CP, Curescu M, Ledinghen V, Habersetzer F, Manolakopoulos S, Negri E, Papatheodoridis G, Ahlers S, Castillo M, Bakalos G, Mauss S; PegBase Group Investigators.

Ann Gastroenterol. 2017;30(3):327-343. doi: 10.20524/aog.2017.0136. Epub 2017 Mar 23.

50.

The Use of IMMUs in a Water Environment: Instrument Validation and Application of 3D Multi-Body Kinematic Analysis in Medicine and Sport.

Mangia AL, Cortesi M, Fantozzi S, Giovanardi A, Borra D, Gatta G.

Sensors (Basel). 2017 Apr 22;17(4). pii: E927. doi: 10.3390/s17040927.

Supplemental Content

Loading ...
Support Center